Related Experiment Videos

[Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age]

D Portaleone1, F Taroni, S Micheli

  • 1Seconda Clinica Pediatrica G. e D. De Marchi, Università degli Studi di Milano, Milano, Italy. dario.portaleone@unimi.it

Minerva Pediatrica
|May 24, 2007
PubMed

Insights

Incontinentia Pigmenti (IP) is a rare genetic skin disorder affecting neuroectodermal tissues. This study outlines a diagnostic protocol and analyzes the clinical spectrum of IP in 82 European patients.

Area of Science:

  • Genetics and Developmental Biology
  • Dermatology
  • Neurology

Context:

  • Incontinentia Pigmenti (IP) is an X-linked dominant disorder affecting skin, neurological, and ophthalmologic systems.
  • Mutations in the NEMO gene, crucial for NF-kB pathway activation, cause IP.
  • The disorder predominantly affects females due to lethality in males in utero.

Purpose:

  • To present a diagnostic protocol for Incontinentia Pigmenti.
  • To conduct a meta-analysis of the clinical spectrum of IP.
  • To review European literature on IP from 2000-2006.

Summary:

  • The study details a diagnostic protocol for Incontinentia Pigmenti.
  • A meta-analysis reviewed 82 cases of IP from European literature (2000-2006).
  • Findings characterize the clinical manifestations and genetic basis (NEMO gene mutations) of IP.

Impact:

  • Provides a framework for diagnosing Incontinentia Pigmenti.
  • Enhances understanding of the diverse clinical presentations of IP.
  • Contributes to the knowledge base for managing this rare genetic disorder.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...